Effects of liver tests taken at admission and intra-admission changes in liver tests upon 12-month mortality
| Model 1: Without liver tests | Model 2: With admission liver tests | Model 3: With intra-admission changes in liver tests | ||||
|---|---|---|---|---|---|---|
| Deceased at 12 months | OR (95% CI) | p Value | OR (95% CI) | p Value | OR (95% CI) | p Value |
| Age | 1.06 (1.05 to 1.06) | <0.001 | 1.06 (1.05 to 1.07) | <0.001 | 1.06 (1.05 to 1.07) | <0.001 |
| Female | 0.74 (0.63 to 0.88) | 0.001 | 0.74 (0.62 to 0.87) | <0.001 | 0.74 (0.62 to 0.88) | 0.001 |
| Charlson Index | ||||||
| 0 | 1 | 1 | 1 | |||
| 1 | 1.47 (1.15 to 1.87) | <0.001 | 1.47 (1.15 to 1.87) | <0.001 | 1.48 (1.16 to 1.89) | <0.001 |
| ≥2 | 1.91 (1.5 to 2.44) | 1.93 (1.51 to 2.46) | 1.88 (1.47 to 2.41) | |||
| Heart failure | 1.41 (1.15 to 1.71) | 0.001 | 1.38 (1.13 to 1.68) | 0.002 | 1.37 (1.12 to 1.67) | 0.002 |
| Effect of baseline albumin (per 1 g/L) | ||||||
| Baseline <34 g/L | 0.95 (0.93 to 0.98) | 0.001 | 0.93 (0.9 to 0.96) | <0.001 | ||
| Baseline 34–48 g/L | 0.97 (0.94 to 1) | 0.035 | 0.95 (0.92 to 0.98) | 0.003 | ||
| Baseline >48 g/L | 0.8 (0.25 to 2.53) | 0.703 | 0.75 (0.23 to 2.46) | 0.632 | ||
| Effect of intra-admission change in albumin (per 1 g/L change) | ||||||
| Decrement | 1.04 (1.02 to 1.06) | <0.001 | ||||
| Increment | 0.96 (0.92 to 1) | 0.051 | ||||
| Effect of intra-admission change in ALT (per 100 U/L change) | ||||||
| Decrement | 1.01 (0.96 to 1.06) | 0.624 | ||||
| Increment | 1.06 (1.02 to 1.1) | 0.005 | ||||
ALT, alanine aminotransferase.